MedPath

A research of efficacy and safety of oxytocin treatment in children and adolescents with reactive attachment disorder using functional magnetic resonance imaging (fMRI).

Not Applicable
Completed
Conditions
Reactive Attachment Disorder
Registration Number
JPRN-UMIN000013215
Lead Sponsor
niversity of Fukui, Research Center for Child Mental Development, Division of Psychosocial Support for Nurturing
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
55
Inclusion Criteria

Not provided

Exclusion Criteria

1) History of allergy for oxytocin. 2) Subjects who have any other current DSM-IV-TR diagnosis of the following; "Pervasive development disorder", "Attention-deficit/hyperactivity disorder","Schizophrenia and Other Psychotic Disorders","Delirium, Dementia, and Amnestic and Other Cognitive Disorders", "Substance-Related Disorders","eating disorders","personality disorders". 3) Subjects who have a physical disorder with a need of strict diet, or a diagnosis of a severe physical disorder. 4) Women who are breastfeeding, pregnant, possibility of pregnancy, or have a wish of early pregnancy. 5) Subjects who are planned for an immediate therapeutic plan change due to unstable physical or psychological symptoms. 6) Subjects with metalic device in their body. 7) Subjects who, in the Investigator's opinion, might not be suitable for the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
fMRI analysis : Comparison of brain activity change after oxytocin or placebo administration.
Secondary Outcome Measures
NameTimeMethod
plasma oxytocin concentration oxytocin receptor gene polymorphism neuropsychological test
© Copyright 2025. All Rights Reserved by MedPath